Résumés
Résumé
La consommation et la dépendance aux drogues furent longtemps considérées comme un problème typiquement masculin. Néanmoins, bien que l’abus et la dépendance à l’alcool, au cannabis et à la nicotine soient encore plus répandus chez les hommes, les différences de genre en ce qui concerne les stimulants et les opiacés ont largement disparu. Il semblerait également que les motivations pour commencer à consommer, l’escalade vers la dépendance et les taux de cessation diffèrent chez les hommes et les femmes. Les raisons qui expliquent ces différences sont multiples et complexes. Nous allons examiner ici les données des études épidémiologiques et cliniques concernant la consommation de diverses drogues chez des hommes et chez des femmes en contexte des facteurs socioculturels, psychologiques et neurobiologiques.
Mots-clés :
- toxicomanie,
- différence hommes/femmes,
- alcool,
- stimulants,
- opiacés,
- cannabis,
- nicotine
Abstract
Drug use and drug addiction have been traditionally considered to be a male problem, however the gender gap has been decreasing over the past few decades. Thus, while the prevalence of alcohol, cannabis and nicotine dependence is still overall greater among men than among women, sex/gender differences in the abuse of stimulants and opiates seem to have disappeared. Moreover, women appear to be more prone to develop drug dependence, suffer more severe physical and psychological consequences of drug abuse, and have more difficulties quitting the habit. Numerous psychological, socio-cultural and biological factors have been implicated in these changing statistics. For example, while a large proportion of men initiate drug use to induce feelings of elation, energy or focus, women frequently start taking drugs to alleviate pre-existing mental health problems, including high levels of stress, feelings of alienation, depression, anxiety, or post-traumatic stress disorder. This maladaptive self-medication strategy often results in a faster transition to a habitual drug use and eventually a more severe dependence. In addition, the socio-cultural norms (particularly in the Western society) have changed dramatically over the past few decades. Thus, while there is still a more severe stigma and prejudice against women who use drugs (especially if they are pregnant of have children), overall there is much greater acceptance of women’s drug use than it was several decades ago. Moreover, women have much greater access to various drugs of abuse than they used to have. Finally, over the past couple of decades new research started emerging pointing to some neurobiological factors that could also contribute to sex differences in drug addiction. Thus, there is now evidence that dopamine system, which for decades has been strongly implicated in drug reinforcement, is sexually dimorphic. The number of dopaminergic neurons, the density of the dopaminergic terminals, as well as responsiveness of the dopaminergic system to drugs of abuse, has been shown to differ between males and females and it has been shown to be modulated by sex steroid hormones, especially estrogen. For example, female rats exhibit greater motivation to self-administer cocaine than male rats and their motivation is the highest during elevated levels of estrogen. All these psychological, socio-cultural and biological factors that contribute to sex/gender difference in drug use and drug dependence, should be considered while evaluating and treating individuals with drug addiction problem.
Keywords:
- Drug addiction,
- sex/gender differences,
- alcohol,
- stimulants,
- opiates,
- cannabis,
- nicotine
Parties annexes
Bibliographie
- American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (4e éd., texte revu). Washington, DC : American Psychiatric Publishing.
- American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5e éd.). Washington, DC : American Psychiatric Publishing.
- Back, S. E., Payne, R. L., Simpson, A. N. et Brady, K. T. (2010). Gender and prescription opioids : Findings from the National Survey on Drug Use and Health. Addictive Behaviors, 35(11), 1001-1007.
- Becker, J. B. et Cha, J. H. (1989). Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behavioral Brain Research, 35(2), 117-125.
- Becker, J. B. et Hu, M. (2008). Sex differences in drug abuse. Front Neuroendocrinal, 29(1), 36-47.
- Becker, J. B., Perry, N. B. et Westenbroek, C. (2012). Sex differences in the neural mechanisms mediating addiction : A new synthesis and hypothesis. Biology of Sex Differences, 3(1), 3-14.
- Brady, K. T. et Randall, C. L. (1999). Gender differences in substance use disorders. The Psychiatric Clinics of North America, 22(2), 241-252.
- Bryant, J. et Treload, C. (2007). The gendered context of initiation to injection drug use : Evidence for women as active initiates. Drug and Alcohol Review, 26(3), 287-293.
- Carroll, M. E., Lynch, W. J., Roth, M. E., Morgan, A. D. et Cosgrove, K. P. (2004). Sex and estrogen influence drug abuse. Trends in Pharmacological Sciences, 25(5), 273-279.
- Cepeda-Benito, A., Reynoso, J. T. et Erath, S. (2004). Meta-analysis of the efficiency of nicotine replacement therapy for smoking cessation : Differences between men and women. Journal of Consulting and Clinical Psychology, 72(4), 712-722.
- Colliver, J. D., Kroutil, L. A., Dai, L. et Gfroerer, J. C. (2006). Misuse of prescription drugs : Data from the 2002, 2003, and 2004 National Surveys on Drug Use and Health.
- Rockville, MD : Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
- Compton, W. M., Thomas, Y. F., Stinson, F. S. et Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States : Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566-576.
- Conklin, C. A. (2006). Environments as cues to smoke : Implication for human extinction-based research and treatment. Experimental and Clinical Psychopharmacology, 14(1), 12-19.
- Conway, K. P., Compton, W., Stinson, F. S. et Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders : Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 67(2), 247-257.
- Cotto, J. H., Davis, E., Dowling, G. J., Elcano, J. C., Staton, A. B. et Weiss, S. R. (2010). Gender effects on drug use, abuse, and dependence : A special analysis of results from the National Survey on Drug Use and Health. Gender Medicine, 7(5), 402-413.
- DiFranza, J. R., Savageau, J. A., Rigotti, N. A., Fletcher, K., Ockene, J. K., McNeill, A. D., Coleman, M. et Wood, C. (2002). Development of symptoms of tobacco dependence in youths : 30 month follow up data from the DANDY study. Tobacco Control, 11(3), 228-235.
- Dransfield, M. T., Davis, J. J., Gerald, L. B. et Bailey, W. C. (2006). Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respiratory Medicine, 100(6), 1110-1116.
- Evans, S. M.,et Foltin, R. W. (2006). Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology, 31(3), 659-674.
- Fattore, L., Altea, S. et Fratta, W. (2008). Sex differences in drug addiction : A review of animal and human studies. Women’s Health, 4(1), 51-65.
- Fattore, L. et Fratta, W. (2010). How important are sex differences in cannabinoid addiction ? British Journal of Pharmacology, 160(3), 544-548.
- Fiore, M. C. (1992). Trends in cigarette smoking in the United States. The epidemiology of tobacco use. Medical Clinics of North America, 76(2), 289-303.
- Frajzyngier, V., Neaigus, A., Gyarmathy, V. A, Miller, M. et Friedman, S. R. (2007). Gender differences in injection risk behaviors at the first injection episode. Drug and Alcohol Dependence, 89(2-3), 145-152.
- Goldstein, R. B. (2008). Comorbidity of substance use with independent mood and anxiety disorders in women : Results from the National Epidemiologic Survey on Alcohol and Related Conditions. In : Brady K. T., Back S. E. et Greenfield S. F. (dir.). Women and addiction : A comprehensive handbook, (173-192). New York : Guilford Press.
- Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kroop, F., McHugh, R. K., Lincoln, M., Hein, D. et Miele, G. M. (2007). Substance abuse treatment entry, retention, and outcome in women : A review of the literature. Drug and Alcohol Dependence, 86(1), 1-21.
- Griffin, M. L., Weiss, R. D., Mirin, S. M. et Lange, U. (1989). A comparison of male and female cocaine abusers. Archives of General Psychiatry, 46(2), 122-126.
- Grucza, R. Z., Norberg, K., Bucholz, K. K. et Bierut, L. J. (2008). Correspondence between secular changes in alcohol dependence and age of drinking onset among women in the United States. Alcoholism, Clinical and Experimental Research, 32(8), 1493-1501.
- Haney, M. (2007). Opioid antagonism of cannabinoid effects : Differences between marijuana smokers and nonmarijuana smokers. Neuropsychopharmacology, 32(6), 1391-1403.
- Hansin, D. S., Keyes, K. M., Alderson, D., Wang, S., Aharanovich, E. et Grant, B. F. (2008). Cannabis withdrawal in the United States : Results from NESARC. Journal of Clinical Psychiatry, 69(9), 1354-1363.
- Hensing, G. et Spak, F. (2009). Introduction : Gendering socio cultural alcohol and drug research. Alcohol and Alcoholism, 44(6), 602-606.
- Hernandez-Avila, C. A., Rounsaville, B. J. et Kranzler, H. R. (2004). Opioid-, cannabis-, and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence, 74(3), 265-272.
- Jackson, L. R., Robinson, T. E. et Becker, J. B. (2006). Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology, 31(1), 129-138.
- Johnson, M. L., Ho, C. C., Day, A. E., Walker, Q. D., Francis, R. et Kuhn, C. M. (2010). Oestrogen receptors enhance dopamine neurone survival in rat midbrain. Journal of Neuroendocrinology, 22(4), 226-237.
- Kandall, S. R. (2010). Women and drug addiction : A historical perspective. Journal of Addictive Diseases, 29(2), 117-126.
- Kelley, S. M., Schwartz, R. P., O’Grady, K. E., Mitchell, S. G., Resinger, H. S., Peterson, J. A., Agar, M. H. et Brown, B. S. (2009). Gender differences among in- and out-of-treatment opioid-addicted individuals. American Journal of Drug and Alcohol Abuse, 35(1), 38-42.
- Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R. et Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617-627.
- Kritzer, M. F., Adler, A. et Bethea, C. L. (2003). Ovarian hormone influences on the density of immunoreactivity for tyrosine hydroxylase and serotonin in the primate corpus striatum. Neuroscience, 122(3), 757-772.
- Kuntsche, E. et Muller, S. (2012). Why do young people start drinking ? Motives for first-time alcohol consumption and links to risky drinking in early adolescence. European Addiction Research, 18(1), 34-39.
- Lecca, D., Cacciapaglia, F., Valentini, V., Gronli, J., Spiga, S. et Di Chiara, G. (2006). Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration. Psychopharmacology, 184(3-4), 435-446.
- Leranth, C., Roth, R. H., Elsworth, J. D., Naftolin, F., Horvath, T. L. et Redmond, D. E. (2000). Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates : Implications for Parkinson’s disease and memory. The Journal of Neuroscience : The Official Journal for the Society of Neuroscience, 20(23), 8604-8609.
- Lynch, W. J. (2006). Sex differences in vulnerability to drug self-administration. Experimental and Clinical Psychopharmacology, 14(1), 34-41.
- Lynch, W. J. et Carrol, M. E. (1999). Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology, 144(1), 77-82.
- Madden, M. E. et Shapiro, S. L. (2011). The methadone epidemic : Methadone-related deaths on the rise in Vermont. American Journal of Forensic Medicine and Pathology, 32(2), 131-135.
- Maremmani, I., Stefania, C., Pacini, M., Maremmani, A. G., Carlini, M., Golia, F., Deltito, J. et Dell’Osso, L. (2010). Differential substance abuse patterns distribute according to gender in heroin addicts. Journal of Psychoactive Drugs, 42(1), 89-95.
- McArthur, S., McHale, E. et Gillies, G. E. (2007). The Size and Distribution of Midbrain Dopaminergic Populations are Permanently Altered by Perinatal Glucocorticoid Exposure in a Sex- Region- and Time-Specific Manner. Neuropsychopharmacology, 32(7), 1462-1476.
- Medelson, J. H., Weiss, R., Griffin, M., Mirin, S. M., Teoh, S. K., Mello, N. K. et Lex, B. W. (1991). Some special considerations for treatment of drug abuse and dependence in women. NIDA Research Monograph, 106(1), 313-327.
- Milsted, A., Serova, L., Sabban, E. L., Dunphy, G., Turner, M. E. et Elv, D. L. (2004). Regulation of tyrosine hydroxylase gene transcription by Sry. Neuroscience Letters, 369(3), 203-207.
- Murray, H. E., Pillai, A. V., McArthur, S. R., Razvi, N., Datla, K. P., Dexter, D. T. et Gillies, G. E. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats : Differential actions of estrogen in males and females. Neuroscience, 116(1), 213-222.
- Najavits, L. M. et Lester, K. M. (2008). Gender differences in cocaine dependence, Drug and Alcohol Dependence, 97(1-2), 190-194.
- Newman, J. L. et Mello, N. K. (2009). Neuroactive gonadal steroid hormones and drug addiction in women. In : Brady, K. T., Back, S. E. et Greenfield, S. F. (dir.). Women and Addiction : A Comprehensive Handbook, (35-64). New York : Guilford Press.
- Perkins, K. A. (2001). Smoking cessation in women. Special considerations. CNS Drugs, 15(5), 391-411.
- Perkins, K. A., Doyle, T., Cicoocioppo, M., Conklin, C., Sayette, M. et Caggiula, A. (2006). Sex differences in the influence of nicotine and dose instructions on subjective and reinforcing effects of smoking. Psychopharmacology, 184(3-4), 600-607.
- Pierce, J. P. et Gilpin, E. (1996). How long will today’s new adolescent smoker be addicted to cigarettes ? American Journal of Public Health, 86(2), 253-256.
- Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A. et Yurgelun-Todd, D. (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58(10), 909-915.
- Pope, H. G., Jacobs, A., Mialet, J. P., Yurgelun-Todd, D. et Gruber, S. (1997). Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychotherapy and Psychosomatics, 66(4), 179-184.
- Powis, B., Griffiths, P., Gossop, M. et Strang, J. (1996). The differences between male and female drug users : Community samples of heroin and cocaine users compared. Substance Use and Misuse, 31(5), 529-543.
- Ridenour, T. A., Lanza, S. T., Donny, E. C. et Clark, D. B. (2006). Different lengths of times for progressions in adolescent substance involvement. Addictive Behaviors, 31(6), 962-983.
- Roberts, D. C., Bennett, S. A. et Vickers, G. J. (1989). The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology, 98(3), 408-411.
- Roth, M. E., Cosgrove, K. P. et Carroll, M. E. (2004). Sex differences in the vulnerability to drug abuse : A review of preclinical studies. Neuroscience and Biobehavioral Reviews, 28(6), 533-546.
- Roy, E., Arruda, N. et Bourgois, P. (2011). The growing popularity of prescription opioid injection in downtown Montréal : New challenges for harm reduction. Substance Use et Misuse, 46(9), 1142-1150.
- Rubino, T. et Parolaro, D. (28 septembre 2011). Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. Frontiers in Behavioral Neuroscience, 5(64).
- Scharf, D. et Shiffman, S. (2004). Are there gender differences in smoking cessation, with and without bupropion ? Pooled- and meta-analyses of clinical trials of Bupropion SR. Addiction, 99(11), 1462-1469.
- Simoni-Wastila, L., Ritter, G. et Strickler, G. (2004). Gender and other factors associated with the nonmedical use of abusable prescription drugs. Substance Use et Misuse, 39(1), 1-23.
- Sofuoglu, M., Dudish-Poulsen, S., Nelson, D., Pentel, P. R., Hatsukami, D. K. (1999). Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Experimental and Clinical Psychopharmacology, 7(3), 274-283.
- Swan, G. E., Ward, M. M., Carmelli, D. et Jack, L. M. (1993). Differential rates of relapse in subgroups of male and female smokers. Journal of Clinical Epidemeology, 46(9), 1041-1053.
- Thorner, E. D., Jaszyna-Gasior, M., Epstein, D. H. et Moolchan, E. T. (2007). Progression to daily smoking : Is there a gender difference among cessation treatment seekers ? Substance Use et Misuse, 42(5), 829-835.
- Van Etten, M. L. et Anthony, J. C. (1999). Comparative epidemiology of initial drug opportunities and transitions to first use : Marijuana, cocaine, hallucinogens, and heroin. Drug and Alcohol Dependence, 54(2), 117-125.
- Wagner, F. A. et Anthony, J. C. (2007). Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug and Alcohol Dependence, 86(2-3), 191-198.
- Wilcox, J. et Yates, W. (1993). Gender and psychiatric comorbidity in substance-abusing individuals. The American Journal on Addictions, 2(3), 202-206.
- Wilson, H. W. et Widom, C. S. (2009). A Prospective Examination of the Path from Child Abuse and Neglect to Illicit Drug Use in Middle Adulthood : The Potential Mediating Role of Four Risk Factors. Journal of Youth and Adolescence, 38(3), 340-354.
- Zhang, D., Yang, S., Yang, C., Jin, G. et Zhen, X. (2008). Estrogen regulates responses of dopamine neurons in the ventral tegmental area to cocaine. Psychopharmacology, 199(4), 625-635.